Aillis
Aillis is a Tokyo-based medical device company that develops nodoca, an AI-powered throat camera using computer vision to screen for influenza non-invasively, serving healthcare providers and telemedicine platforms primarily in Japan.
- Company typePrivate
- Founded2017
- HeadquartersTokyo, Japan
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aillis does
Aillis (アイリス株式会社 / Aillis, Inc.) is a Tokyo-based medical device company founded in 2017 that develops AI-powered diagnostic imaging hardware. Its flagship product, nodoca, is an AI-based throat camera that captures pharyngeal images and applies computer vision algorithms to screen for influenza, positioned as a non-invasive alternative to conventional nasal/throat swab antigen testing. The system reportedly achieves approximately 75% concordance with standard antigen testing and currently functions as a screening tool without strain-level differentiation.
The underlying technology centers on proprietary computer vision models trained to identify visual indicators of influenza from throat imagery. Aillis has published peer-reviewed clinical feasibility work, including a February 2026 study in Frontiers in Digital Health, and additional computer vision research such as gender estimation from throat images, demonstrating in-house AI/ML development. The company is headquartered in Tokyo, operates with 51-100 employees, and serves healthcare providers, hospitals, clinics, and telemedicine platforms primarily in Japan.
Aillis has raised approximately $30.9M across disclosed funding rounds between 2019 and 2024, including backing from Beyond Next Ventures, Capital Medica Ventures, Shionogi (pharmaceutical), Mitsui Sumitomo Insurance Venture Capital, Cyberdyne, Mirai Creation Fund, Nissay Capital, and Pegasus Tech Ventures. The company has also participated in Startup World Cup. Pricing is not publicly disclosed, and the business model appears to be B2B device sales or service partnerships with healthcare providers and telemedicine channels, though specific commercial mechanics are not detailed in the available data. No revenue figures have been disclosed.
Aillis firmographics
Firmographics- Name
- Aillis
- Legal name
- アイリス株式会社
- Website
- https://aillis.jp
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Aillis is a Tokyo-based medical device company that develops nodoca, an AI-powered throat camera using computer vision to screen for influenza non-invasively, serving healthcare providers and telemedicine platforms primarily in Japan.
- Ownership category
- akta.pro rank
Aillis industry classification
Industry- Product category
- AI Medical Imaging Devices
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Aillis is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Markets served
Aillis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Marketing channels1 record
Aillis product offering
Product offeringCore offering
Aillis develops and sells nodoca, an AI-based throat camera that captures pharyngeal images and uses computer vision algorithms to screen for influenza without requiring invasive nasal or throat swabs. The device functions as a non-invasive screening tool with approximately 75% concordance to conventional antigen testing. The product is positioned for use by healthcare providers and telemedicine platforms for early-stage influenza detection.
Product overview
Aillis (アイリス株式会社) is an AI medical device developer that has developed nodoca, an AI-based throat camera for influenza screening. The company specializes in computer vision technology applied to medical imaging, particularly throat/咽頭 image analysis. Their portfolio centers on the nodoca product, which uses AI to analyze throat images for influenza diagnosis, reducing patient burden compared to traditional invasive swab testing.
Differentiator
Problem solved
Functional benefit
Products and services
- nodoca AI Throat Camera AI-based throat camera device for non-invasive influenza screening and early detection. The product captures throat images and analyzes them using AI computer vision algorithms, eliminating the need for invasive nasal/throat swabs. It functions as a screening tool with approximately 75% concordance with conventional antigen testing, targeted at healthcare providers, hospitals, clinics, and telemedicine platforms.
Quantifiable outcome
- Approximately 75% concordance with conventional antigen testing for influenza diagnosis
Companies that use Aillis
Customer profileSegments1 record
Ideal customer profiles1 record
Aillis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature2 records
Aillis partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Aillis competitors and assessment
Company assessmentDirect peers
- Aidoc: Israel-based AI medical imaging platform providing triage and workflow tools across CT, MRI, and X-ray. Direct peer in computer-vision-based diagnostic imaging for clinical workflows.
- Viz.ai: AI imaging company using deep learning to triage stroke and other time-sensitive conditions from CT. Direct peer in AI image-based clinical workflow and triage, comparable regulatory and clinical-validation trajectory.
- Lunit: Korean AI medical imaging company with FDA-cleared algorithms for mammography and chest X-ray triage. Direct peer in AI-driven medical image diagnostics with similar software-as-medical-device positioning.
- AI Medical Service Inc. Japan-based AI medical device company applying deep learning to endoscopic imaging for cancer detection. Closest direct peer — same Japanese domicile, same AI-imaging-for-diagnostics category, same medical-device regulatory pathway.
- Nanox (Zebra Medical Vision): Imaging AI company (formerly Zebra Medical Vision) offering AI analytics across radiology modalities. Direct peer in AI-augmented medical image interpretation with a multi-disease platform model.
- Qure.ai: AI medical imaging company focused on radiology AI for chest, head, and musculoskeletal imaging. Direct peer in deep-learning image analysis for diagnostic decision support.
Emerging players
- Cue Health: Connected at-home molecular diagnostic platform including respiratory pathogens. Emerging player in non-laboratory, consumer/clinical-grade respiratory testing that competes for the same remote-screening use case as nodoca.
Regional players
- MedPeer: Japanese physician-consultation and telemedicine platform that could integrate or distribute Aillis-style diagnostic tools. Regional channel partner / potential customer rather than a direct diagnostic competitor.
Broad incumbents
- QuidelOrtho: Established diagnostics company with the Sofia rapid antigen platform, a dominant incumbent in point-of-care influenza testing — the incumbent workflow Aillis is attempting to augment or replace.
- Abbott Diagnostics (BinaxNOW): Global diagnostics incumbent with BinaxNOW rapid antigen tests for influenza — the category-defining standard-of-care workflow that Aillis's nodoca would need to displace or complement at point-of-care.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Aillis social profiles
Digital presenceAillis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aillis leadership team
Management profileNumber of profiles
Profiles5 records
Aillis funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aillis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aillis
What does Aillis do?
Aillis develops and sells nodoca, an AI-based throat camera that captures pharyngeal images and uses computer vision algorithms to screen for influenza without requiring invasive nasal or throat swabs. The device functions as a non-invasive screening tool with approximately 75% concordance to conventional antigen testing. The product is positioned for use by healthcare providers and telemedicine platforms for early-stage influenza detection.
Is Aillis a public or private company?
Aillis is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aillis founded?
Aillis was founded in 2017. It employs 51 to 100 people.
Where is Aillis based?
Aillis is headquartered in Tokyo, Japan, in the Asia region.
Who are Aillis's main competitors?
Direct peers on record are Aidoc, Viz.ai, Lunit, AI Medical Service Inc., Nanox (Zebra Medical Vision) and Qure.ai. Cue Health is listed as an emerging player. MedPeer is listed as a regional player. Broad incumbents are QuidelOrtho and Abbott Diagnostics (BinaxNOW).
Does Aillis have an API?
No public API is recorded for Aillis.
What industry is Aillis in?
Aillis's product category is AI Medical Imaging Devices. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 3345 and its SIC code is 3841.